Toxicity of dual HER2-blockade with pertuzumab added to anthracycline versus non-anthracycline containing chemotherapy as neoadjuvant treatment in HER2-positive breast cancer: The TRAIN-2 study

Bibliographic Details
Title: Toxicity of dual HER2-blockade with pertuzumab added to anthracycline versus non-anthracycline containing chemotherapy as neoadjuvant treatment in HER2-positive breast cancer: The TRAIN-2 study
Authors: van Ramshorst, Mette S., van Werkhoven, Erik, Honkoop, Aafke H., Dezentjé, Vincent O., Oving, Irma M., Mandjes, Ingrid A., Kemper, Inge, Smorenburg, Carolien H., Stouthard, Jacqueline M., Linn, Sabine C., Sonke, Gabe S.
Source: In The Breast October 2016 29:153-159
Database: ScienceDirect
More Details
ISSN:09609776
DOI:10.1016/j.breast.2016.07.017
Published in:The Breast
Language:English